Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing biliary tract cancer (BTC) and pancreatic cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02)

被引：0

作者：

Oh, Do-Youn

Lugowska, Iwona A.

Stroyakovskiy, Daniil

Jung, Kyung Hae

Dumas, Olivier

Penkov, Konstantin

Dechaphunkul, Arunee

Oaknin, Ana

Kim, Seung Tae

Starling, Naureen

Chewaskulyong, Busyamas

Charonpongsuntorn, Chanchai

Doroshow, Deborah Blythe

Hsiao, Sheng-Yen

Hung, Yi-Ping

Jung, Lindsey

Kuptsova-Clarkson, Nataliya

Michelini, Flavia

Puvvada, Soham D.

Meric-Bernstam, Funda

机构：

[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[2] Maria Sklodowska Curie Natl Res Inst & Oncol Ctr, Early Phase Clin Trials Dept, Warsaw, Poland

[3] Moscow City Oncol Hosp 62, Moscow, Russia

[4] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea

[5] Hotel Dieu Quebec, Quebec City, PQ, Canada

[6] Clin Hosp RZHD Med, St Petersburg, Russia

[7] Prince Songkla Univ, Dept Med, Med Oncol Unit, Fac Med, Hat Yai, Thailand

[8] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Gynaecol Canc Programme, Barcelona, Spain

[9] Samsung Med Ctr, Seoul, South Korea

[10] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[11] Inst Canc Res, London, England

[12] Chiang Mai Univ, Chiang Mai, Thailand

[13] Srinakharinwirot Univ, Dept Internal Med, Med Oncol Unit, Fac Med, Nakhon Nayok, Thailand

[14] Icahn Sch Med Mt Sinai, New York, NY USA

[15] Chi Mei Med Ctr, Div Hematol Oncol, Dept Internal Med, Tainan, Taiwan

[16] Taipei Vet Gen Hosp, Taipei, Taiwan

[17] AstraZeneca, Gaithersburg, MD USA

[18] AstraZeneca, Oncol R&D, Gaithersburg, MD USA

[19] AstraZeneca, Translat Med, Oncol R&D, Waltham, MA USA

[20] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4090

引用

页数：1